PVB与BEP交替周期治疗晚期精原细胞瘤的疗效观察

Jourik A. Gietema , Pax H.B. Willemse , Nanno H. Mulder , Jan Oldhoff , Elisabeth G.E. de Vries , Dirk Th. Sleijfer
{"title":"PVB与BEP交替周期治疗晚期精原细胞瘤的疗效观察","authors":"Jourik A. Gietema ,&nbsp;Pax H.B. Willemse ,&nbsp;Nanno H. Mulder ,&nbsp;Jan Oldhoff ,&nbsp;Elisabeth G.E. de Vries ,&nbsp;Dirk Th. Sleijfer","doi":"10.1016/0277-5379(91)90013-4","DOIUrl":null,"url":null,"abstract":"<div><p>33 patients (median age 39 years) with advanced seminoma were treated with 4 courses of alternating cisplatin-containing chemotherapy PVB/BEP (cisplatin, vinblastine and bleomycin; bleomycin, etoposide and cisplatin). Patients were classified as stage IIC (<em>n</em> = 7), IID (<em>n</em> = 9), III (<em>n</em> = 13) and IV (<em>n</em> = 4). 8 had had prior radiotherapy; 9 had an elevated beta human chorionic gonadotropin (βHCG). 30 patients were evaluable for response and 33 for toxicity. During chemotherapy 3 patients died, 1 due to malignant disease, another due to a cardiac arrest, and 1 patient of a bleomycin pneumonitis. 13 (43%) had a complete remission and 17 (57%) had a clinical partial remission (residual radiographic mass). At a median follow-up of 28 months (range 16–88), 3 patients relapsed, 6–8 months after entry. After completion of therapy there were 2 deaths, 1 due to bleomycin pneumonitis and 1 neither tumour nor treatment related. 26 of 33 (79%) patients achieved a continuously disease-free status. Leucocytopenia and thrombocytopenia of WHO grade <span><math><mtext>3</mtext><mtext>4</mtext></math></span> occurred in, respectively, <span><math><mtext>32</mtext><mtext>33</mtext></math></span> (97%) and <span><math><mtext>20</mtext><mtext>33</mtext></math></span> (61%) of the patients. This study shows that alternating PVB/BEP in this group yields comparable response rates with non-alternating schedules but at the expense of considerable toxicity.</p></div>","PeriodicalId":11925,"journal":{"name":"European Journal of Cancer and Clinical Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1991-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0277-5379(91)90013-4","citationCount":"6","resultStr":"{\"title\":\"Alternating cycles of PVB and BEP in the treatment of patients with advanced seminoma\",\"authors\":\"Jourik A. Gietema ,&nbsp;Pax H.B. Willemse ,&nbsp;Nanno H. Mulder ,&nbsp;Jan Oldhoff ,&nbsp;Elisabeth G.E. de Vries ,&nbsp;Dirk Th. Sleijfer\",\"doi\":\"10.1016/0277-5379(91)90013-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>33 patients (median age 39 years) with advanced seminoma were treated with 4 courses of alternating cisplatin-containing chemotherapy PVB/BEP (cisplatin, vinblastine and bleomycin; bleomycin, etoposide and cisplatin). Patients were classified as stage IIC (<em>n</em> = 7), IID (<em>n</em> = 9), III (<em>n</em> = 13) and IV (<em>n</em> = 4). 8 had had prior radiotherapy; 9 had an elevated beta human chorionic gonadotropin (βHCG). 30 patients were evaluable for response and 33 for toxicity. During chemotherapy 3 patients died, 1 due to malignant disease, another due to a cardiac arrest, and 1 patient of a bleomycin pneumonitis. 13 (43%) had a complete remission and 17 (57%) had a clinical partial remission (residual radiographic mass). At a median follow-up of 28 months (range 16–88), 3 patients relapsed, 6–8 months after entry. After completion of therapy there were 2 deaths, 1 due to bleomycin pneumonitis and 1 neither tumour nor treatment related. 26 of 33 (79%) patients achieved a continuously disease-free status. Leucocytopenia and thrombocytopenia of WHO grade <span><math><mtext>3</mtext><mtext>4</mtext></math></span> occurred in, respectively, <span><math><mtext>32</mtext><mtext>33</mtext></math></span> (97%) and <span><math><mtext>20</mtext><mtext>33</mtext></math></span> (61%) of the patients. This study shows that alternating PVB/BEP in this group yields comparable response rates with non-alternating schedules but at the expense of considerable toxicity.</p></div>\",\"PeriodicalId\":11925,\"journal\":{\"name\":\"European Journal of Cancer and Clinical Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0277-5379(91)90013-4\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer and Clinical Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0277537991900134\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer and Clinical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0277537991900134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

摘要

33例晚期精原细胞瘤患者(中位年龄39岁)接受4个疗程的含顺铂交替化疗PVB/BEP(顺铂、长春碱和博来霉素;博莱霉素、依托泊苷和顺铂)。患者分为IIC期(n = 7)、IID期(n = 9)、III期(n = 13)和IV期(n = 4)。9例人绒毛膜促性腺激素(βHCG)升高。30例患者可评价反应,33例可评价毒性。在化疗期间,3例患者死亡,1例因恶性疾病,1例因心脏骤停,1例因博来霉素肺炎。13例(43%)完全缓解,17例(57%)临床部分缓解(残余放射学肿块)。中位随访28个月(范围16-88),3例患者在入院后6-8个月复发。治疗结束后,有2例死亡,1例死于博莱霉素肺炎,1例与肿瘤和治疗无关。33例患者中有26例(79%)达到持续无病状态。WHO 34级白细胞减少症和血小板减少症患者分别为3233例(97%)和2033例(61%)。这项研究表明,在该组中交替使用PVB/BEP与非交替方案产生相当的反应率,但代价是相当大的毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Alternating cycles of PVB and BEP in the treatment of patients with advanced seminoma

33 patients (median age 39 years) with advanced seminoma were treated with 4 courses of alternating cisplatin-containing chemotherapy PVB/BEP (cisplatin, vinblastine and bleomycin; bleomycin, etoposide and cisplatin). Patients were classified as stage IIC (n = 7), IID (n = 9), III (n = 13) and IV (n = 4). 8 had had prior radiotherapy; 9 had an elevated beta human chorionic gonadotropin (βHCG). 30 patients were evaluable for response and 33 for toxicity. During chemotherapy 3 patients died, 1 due to malignant disease, another due to a cardiac arrest, and 1 patient of a bleomycin pneumonitis. 13 (43%) had a complete remission and 17 (57%) had a clinical partial remission (residual radiographic mass). At a median follow-up of 28 months (range 16–88), 3 patients relapsed, 6–8 months after entry. After completion of therapy there were 2 deaths, 1 due to bleomycin pneumonitis and 1 neither tumour nor treatment related. 26 of 33 (79%) patients achieved a continuously disease-free status. Leucocytopenia and thrombocytopenia of WHO grade 34 occurred in, respectively, 3233 (97%) and 2033 (61%) of the patients. This study shows that alternating PVB/BEP in this group yields comparable response rates with non-alternating schedules but at the expense of considerable toxicity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Preclinical evaluation of polymer-bound doxorubicin Corrections News Introduction Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1